| Romulo Corrada, MD | |
|
7121 S Spid Dr, Ste 200, Corpus Christi, TX 78412-4940 | |
| (361) 993-6000 | |
| (361) 993-3676 |
| Full Name | Romulo Corrada |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 29 Years |
| Location | 7121 S Spid Dr, Corpus Christi, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114924446 | NPI | - | NPPES |
| 044719501 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 08971 (Texas) | Secondary |
| 207V00000X | Obstetrics & Gynecology | J8971 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Coastal Bend Womens Center | 7911991914 | 10 |
News Archive
ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the fourth quarter ended December 31, 2009.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.
A team of scientists at Sweden's Linköping University have developed a molecular probe that can detect an array of different amyloid deposits in several human tissues. This new probe is extremely sensitive and was used at very low concentrations to correctly identify every positive amyloidosis sample when compared to the traditional clinical tests.
Italian study results confirm that a multivariate serum protein test predicts improved survival after treatment with chemotherapy versus erlotinib for non-small-cell lung cancer, but only among patients who are likely to have a poor outcome with the latter treatment type.
› Verified 8 days ago
| Entity Name | Coastal Bend Womens Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891812483 PECOS PAC ID: 7911991914 Enrollment ID: O20040413000431 |
News Archive
ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the fourth quarter ended December 31, 2009.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.
A team of scientists at Sweden's Linköping University have developed a molecular probe that can detect an array of different amyloid deposits in several human tissues. This new probe is extremely sensitive and was used at very low concentrations to correctly identify every positive amyloidosis sample when compared to the traditional clinical tests.
Italian study results confirm that a multivariate serum protein test predicts improved survival after treatment with chemotherapy versus erlotinib for non-small-cell lung cancer, but only among patients who are likely to have a poor outcome with the latter treatment type.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Romulo Corrada, MD 7121 S Spid Dr, Ste 200, Corpus Christi, TX 78412-4940 Ph: (361) 993-6000 | Romulo Corrada, MD 7121 S Spid Dr, Ste 200, Corpus Christi, TX 78412-4940 Ph: (361) 993-6000 |
News Archive
ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the fourth quarter ended December 31, 2009.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.
A team of scientists at Sweden's Linköping University have developed a molecular probe that can detect an array of different amyloid deposits in several human tissues. This new probe is extremely sensitive and was used at very low concentrations to correctly identify every positive amyloidosis sample when compared to the traditional clinical tests.
Italian study results confirm that a multivariate serum protein test predicts improved survival after treatment with chemotherapy versus erlotinib for non-small-cell lung cancer, but only among patients who are likely to have a poor outcome with the latter treatment type.
› Verified 8 days ago
Sultana Alamin Khimani, MD Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 5920 Saratoga Blvd, Suite 570, Corpus Christi, TX 78414 Phone: 361-985-8100 Fax: 361-985-8131 | |
Danielle Alicia Inman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7121 S Padre Island Dr, Suite 302, Corpus Christi, TX 78412 Phone: 361-851-5000 Fax: 361-851-8053 | |
Dr. Jeffery Blaine Itkin, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5920 Saratoga Boulevard, Suite 540, Corpus Christi, TX 78414 Phone: 361-883-6030 Fax: 361-883-6442 | |
Mrs. Leighanne Glazener, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7121 S Padre Island Dr, Suite 302, Corpus Christi, TX 78412 Phone: 361-851-5000 Fax: 361-851-8053 | |
Christine L Canterbury, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7121 Spid, Suite 302, Corpus Christi, TX 78412 Phone: 361-851-5000 Fax: 361-851-0590 | |
Juan A Villarreal, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 13725 Northwest Blvd, Suite #110, Corpus Christi, TX 78410 Phone: 361-387-7177 Fax: 361-387-8355 |